Navigation
Recherche
|
Moderna Says mRNA Flu Vaccine Sailed Through Trial, Beating Standard Shot
samedi 5 juillet 2025, 01:30 , par Slashdot
![]() The company announced that mRNA-1010 had an overall vaccine efficacy that was 26.6% higher than conventional shots, rising to 27.4% higher in participants aged 65 and older during the six-month study period. The 2024-2025 flu season hospitalized an estimated 770,000 Americans, according to the Centers for Disease Control and Prevention. Read more of this story at Slashdot.
https://science.slashdot.org/story/25/07/04/1753246/moderna-says-mrna-flu-vaccine-sailed-through-tri...
Voir aussi |
56 sources (32 en français)
Date Actuelle
sam. 5 juil. - 15:31 CEST
|